News
Participants in the 1-year, single-center study included 47 patients with RA and 56 with PsA. All were receiving TNF inhibitors and were in remission or had low disease activity, defined as a ...
We’re witnessing a renaissance in cytokine targeting,” says Dr. Emily Rhodes, immunologist at the Stanford Institute for ...
Anti-TNF drugs have revolutionized the treatment of rheumatoid arthritis (RA). Concerns about risks of infection and malignancy with these agents have led to scrutiny of available data.
HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations ...
Tumor necrosis factor α (TNF-α) has a central role in the pathogenesis of rheumatoid arthritis, 1–3 as demonstrated by the clinical benefit of TNF-α–neutralizing therapy 4–9 with either a ...
Etanercept is the only US FDA-approved TNF antagonist for juvenile rheumatoid arthritis. TNF-α antagonists may improve some clinical manifastations of Behçet's disases, including uveitis.
This designation is meaningful as it signifies our continued commitment to making biosimilars more accessible. Both biosimilars and interchangeable biosimilars are highly similar and have no ...
Anaptys Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2b Trial in RA
Favorable safety and tolerability, particularly when compared to standard of care biologics or JAKs Max response rates have not yet been observed; strict continuation criteria at three months in this ...
Hyderabad: Bamboo rice, the edible seeds of Bambusa arundinacea, demonstrated anti-inflammatory effects in a study conducted ...
AnaptysBio announces positive results from phase 2b trial of rosnilimab to treat rheumatoid arthritis: San Diego Thursday, June 5, 2025, 18:00 Hrs [IST] AnaptysBio, Inc., a clinic ...
How CD4+ T cells respond to Chikungunya virus may trigger long-lasting joint pain, mimicking autoimmune disease long after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results